Term ends Sep 30, 2029 · High confidence
20-year base term ends Sep 30, 2029
Held by Agrisoma Biosciences Inc.
Filed Sep 2, 2016 as application 15/256,244 · Granted Sep 25, 2018
Base term, 20 years from filing
Today
2009
2029
Clock starts
Sep 30, 2009
Sep 30, 2009
Term ends
Sep 30, 2029
Sep 30, 2029
Granted
Sep 25, 2018
Sep 25, 2018
base term
fee events
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,546,645, to Sep 30, 2029. The term already ends on or before that date, so the cap shortened nothing.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 2 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 30, 2009, when application 12/571,012, the earliest non-provisional in its chain, was filed (this one was filed Sep 2, 2016) | Sep 30, 2029 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,546,645) | resolves to Sep 30, 2029, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Sep 30, 2029 | High confidence |
This family
| US 8,546,645 | In force Apr 2031 | Apr 2031 |
| Application 14/024,220 | Abandoned not computed | not computed |
| US 10,081,815 | this patent Sep 2029 | Sep 2029 |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 22, 2018 Reel 45540, frame 689 | Agrisoma Biosciences Inc. | Cycle Capital Fund III, L.P. | Intellectual Property Security Agreement |
| Mar 22, 2018 Reel 45668, frame 909 | Agrisoma Biosciences Inc. | John Plaza | Intellectual Property Security Agreement |
| Mar 22, 2018 Reel 45668, frame 948 | Agrisoma Biosciences Inc. | BDC Capital Inc. | Intellectual Property Security Agreement |
| Mar 22, 2018 Reel 45669, frame 435 | Agrisoma Biosciences Inc. | Capital Regional et Cooperatif Desjardins | Intellectual Property Security Agreement |
| Mar 22, 2018 Reel 45669, frame 529 | Agrisoma Biosciences Inc. | Gestion Manuia Inc. | Intellectual Property Security Agreement |
| Jan 25, 2019 Reel 48132, frame 194 | Agrisoma Biosciences Inc. | Cycle Capital Fund III, L.P. | Security Interest |
| Jan 25, 2019 Reel 48132, frame 551 | Agrisoma Biosciences Inc. | Capital Régional et Coopératif Desjardins | Security Interest |
| Jan 29, 2019 Reel 48162, frame 491 | Agrisoma Biosciences Inc. | Cycle Capital Fund III, L.P. | Security Interest |
| Jan 29, 2019 Reel 48162, frame 518 | Agrisoma Biosciences Inc. | Capital Régional et Coopératif Desjardins | Security Interest |
| Jan 29, 2019 Reel 48162, frame 529 | Agrisoma Biosciences Inc. | Gestion Manuia Inc. | Security Interest |
| Jan 31, 2019 Reel 48199, frame 227 | Agrisoma Biosciences Inc. | BDC Capital Inc. | Security Interest |
| Jan 31, 2019 Reel 48199, frame 246 | Agrisoma Biosciences Inc. | Capital Régional et Coopératif Desjardins | Security Interest |
| Jan 31, 2019 Reel 48199, frame 285 | Agrisoma Biosciences Inc. | Cycle Capital Fund III, L.P. | Security Interest |
| Sep 17, 2019 Reel 50395, frame 72 | Agrisoma Biosciences Inc. | BDC Capital Inc. | Security Interest |
| Sep 17, 2019 Reel 50395, frame 355 | Agrisoma Biosciences Inc. | Capital Regional et Cooperatif Desjardins | Security Interest |
| Sep 17, 2019 Reel 50395, frame 432 | Agrisoma Biosciences Inc. | Gestion Manuia Inc. | Security Interest |
| Sep 17, 2019 Reel 50395, frame 646 | Agrisoma Biosciences Inc. | Cycle Capital Fund III, L.P. | Security Interest |
| Sep 17, 2019 Reel 50395, frame 872 | Agrisoma Biosciences Inc. | Plaza, John | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Sep 2029
Term ends Sep 30, 2029. No further fees fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 8,546,645, ends no earlier than this term, so it caps nothing.
Citations
6
later US patents cite this one
That is above the median of utility patents granted in 2018 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.